Drug repositioning based on weighted local information augmented graph neural network.
Ontology highlight
ABSTRACT: Drug repositioning, the strategy of redirecting existing drugs to new therapeutic purposes, is pivotal in accelerating drug discovery. While many studies have engaged in modeling complex drug-disease associations, they often overlook the relevance between different node embeddings. Consequently, we propose a novel weighted local information augmented graph neural network model, termed DRAGNN, for drug repositioning. Specifically, DRAGNN firstly incorporates a graph attention mechanism to dynamically allocate attention coefficients to drug and disease heterogeneous nodes, enhancing the effectiveness of target node information collection. To prevent excessive embedding of information in a limited vector space, we omit self-node information aggregation, thereby emphasizing valuable heterogene
SUBMITTER: Meng Y
PROVIDER: S-EPMC10686358 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA